CHRISTY STEWART: Open Payments
NPI 1881948750 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 17 payments from 9 companies in 2025. Trend: 2023 $413 · 2024 $328 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $159 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| GENZYME CORPORATION | 2 | $44 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Genentech USA, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Cochlear Americas | 1 | $22 |
| Amgen Inc. | 1 | $18 |
Products named: DUPIXENT, INSPIRE, NEFFY, Xolair, FASENRA, VOQUEZNA, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, AYVAKIT.
Industry payments across TX — which companies pay providers there.
